Bayer BAYN-0.26%decrease; red down pointing triangle said it agreed to buy Perfuse Therapeutics for up to $2.45 billion, snapping up an eye-drug specialist that is developing a potential glaucoma ...

Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to $2.15 billion in milestones, will give Bayer control of an eye disease implant that ...

This is the first in a three-part series on Bayer’s crusade for immunity from Roundup-related cancer claims, published in partnership with the Center for Media and Democracy. Read the second and third ...

With a fresh phase 3 win for Kerendia, Bayer is one step closer to pushing the ascendant drug into a much broader population of patients with chronic kidney disease (CKD). Kerendia, also known as ...

Bayer is proposing a $7.25 billion plan to settle thousands of lawsuits claiming its Roundup weedkiller caused cancer — a high-stakes effort to cap years of mounting legal exposure that will pressure ...

Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin ...

Bayer BAYN-3.46%decrease; red down pointing triangle is making a new multibillion-dollar push to resolve a yearslong legal nightmare over Roundup weedkiller. The German pharmaceutical and agriculture ...

The agreement, which still faces legal hurdles, would cover current and future claims that the weedkiller caused non-Hodgkin’s lymphoma. By Kevin Draper Bayer, the German pharmaceutical and biotech ...

JEFFERSON CITY, Mo. — Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging the company failed ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

When Bayer CEO Bill Anderson launched his Dynamic Shared Ownership (DSO) layoff plan—designed to save 2 billion euros ($2.3 billion) in 2026—he said it would be completed by the “end of 2025 at the ...

Pittsburg, PA, June 23, 2010--Bayer MaterialScience said it has successfully developed ultraviolet polyurethane dispersions (UV PUDs) for use in waterborne site-applied floor coatings, offering ...